Bone 2012
Moise H, Adachi JD, Chettle DR, Pejović-Milić A
A previously developed in
vivo X-ray fluorescence (IVXRF) I-125 based system was used to measure
bone strontium levels non-invasively in an osteoporotic female
volunteer. The volunteer was recruited in December 2008, as part of the
Ryerson and McMaster University Strontium in Bone Research Study and
measured at twice weekly, weekly and monthly intervals. Thirty minute
measurements were taken at the finger and ankle bone sites, representing
primarily cortical and trabecular bone, respectively and the strontium
K-alpha X-ray peak at 14.16 keV was used in the analysis.
Since the volunteer had no prior history of strontium based medications
or supplementation, baseline natural strontium levels were obtained
followed by a 24h measurement of first intake of strontium citrate
supplements (680 mg Sr/day). While the baseline levels of 0.38 ± 0.05
and 0.39 ± 0.10 for the finger and ankle, respectively, were on par with
those previously reported in Caucasians among twenty-two healthy
non-supplementing strontium individuals by our group, an increase began
to be seen after 24 hrs of 0.62 ± 0.14 and 0.45 ± 0.12 for the finger
and ankle, respectively. By 120 h, the increase was statistically
significant at 0.68 ± 0.07 and 0.93 ± 0.05, respectively. Further
increases occurred within an interval of 90-180 days, with the most
recent, after 800 days, at the finger and ankle being 7 and 15 times
higher than the initial baseline reading.
The intriguing
results show bone strontium incorporation and retention follow a
pattern, suggesting strontium levels, at least in the ankle, do not
plateau within two to three years and will continue to increase over
time, as an individual takes strontium supplements. The ability of this
IVXRF system to monitor and measure bone strontium levels over time
provides a useful diagnostic tool to help gain insight into strontium
bone kinetics.
http://www.ncbi.nlm.nih.gov/pubmed/22549020
Skeleton Pirate
WELCOME TO STRONTIUM FOR BONES BLOG
Have you experienced negative, and even dangerous, side effects from Fosamax (alendronate), Boniva (ibandronate), Actonel (risedronate), Reclast (zoledronic acid), Prolia (denosumab), Forteo (teriparatide), Tymlos (abaloparatide), or other drugs prescribed for osteoporosis? If you have, then rest assured there is a safe, effective treatment for this condition. Strontium, primarily in the form of strontium citrate, is taken orally once a day.
Visitors to my blog can leave comments or ask questions and can remain anonymous, if they wish. Their comments are relayed to my g-mail inbox. Below each post, the number of comments for that post is cited and underlined because it is a link. By clicking on that link below any post, a window opens so that a visitor can leave a comment. Ideally, visitors leave comments on posts most relevant to their comments. All comments to my posts are moderated by me.
Browse the posts and visit the link library of references.
Visitors to my blog can leave comments or ask questions and can remain anonymous, if they wish. Their comments are relayed to my g-mail inbox. Below each post, the number of comments for that post is cited and underlined because it is a link. By clicking on that link below any post, a window opens so that a visitor can leave a comment. Ideally, visitors leave comments on posts most relevant to their comments. All comments to my posts are moderated by me.
Browse the posts and visit the link library of references.
Subscribe to:
Post Comments (Atom)
Wandering Skeleton
Osteoporotic Bone
How Strontium Builds Bones
Strontium is a mineral that tends to accumulate in bone. Studies have shown that oral doses of strontium are a safe and effective way to prevent and reverse osteoporosis. Doses of 680 mg per day appear to be optimal. See my "For More Information About Strontium" links section.
Osteoporosis is caused by changes in bone production. In healthy young bones there is a constant cycle of new bone growth and bone removal. With age, more bone is removed and less new bone is produced. The bones become less dense and thus more fragile.
Scientists believe that strontium works in two ways. It may stimulate the replication of pre-osteoblasts, leading to an increase in osteoblasts (cells that build bone). Strontium also directly inhibits the activity of osteoclasts (cells that break down bone). The result is stronger bones.
When taking strontium, be sure to take 1200 mg calcium, 1000 IU vitamin D3, and 500 mg magnesium daily. It is best to take strontium late at night on an empty stomach. Calcium and strontium may compete with each other for absorption if taken together.
Osteoporosis is caused by changes in bone production. In healthy young bones there is a constant cycle of new bone growth and bone removal. With age, more bone is removed and less new bone is produced. The bones become less dense and thus more fragile.
Scientists believe that strontium works in two ways. It may stimulate the replication of pre-osteoblasts, leading to an increase in osteoblasts (cells that build bone). Strontium also directly inhibits the activity of osteoclasts (cells that break down bone). The result is stronger bones.
When taking strontium, be sure to take 1200 mg calcium, 1000 IU vitamin D3, and 500 mg magnesium daily. It is best to take strontium late at night on an empty stomach. Calcium and strontium may compete with each other for absorption if taken together.
For More Information about Strontium
- A Dose-response Study With Strontium Malonate
- A Review of the latest insights into the mechanism of action of strontium in bone
- Antifracture Efficacy Over 10 Years With Strontium Ranelate
- Combination of Micronutrients for Bone (COMB) Study: Bone Density after Micronutrient Intervention
- Echolight REMS Scan of Young, Normal Female
- Effect of bone strontium on BMD measurements
- Effect of Lumbar Scoliosis on DXA Results
- Effects of SrR on Calcium Metabolism
- Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection
- Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry
- Interpretation of BMD Scans in Patients Stopping Strontium
- Melatonin-micronutrients Osteopenia Treatment Study (MOTS)
- National Osteoporosis Foundation
- Osteoporosis And Bone Physiology
- Post-Marketing Assessment of the Safety of Strontium Ranelate
- PubMed Abstract On The SOTI Study
- PubMed Abstract On The TROPOS Study
- Strontium ranelate Aristo
- Strontium Ranelate For Spinal Osteoarthritis
- Strontium: Breakthrough Against Osteoporosis
- Summary Safety Review - Strontium
- The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment
- Thirteen Key Diagnostic Tests
No comments:
Post a Comment